Average Co-Inventor Count = 5.31
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (11 from 3,923 patents)
2. Nido Biosciences, Inc. (4 from 4 patents)
15 patents:
1. 12448368 - Indole compounds as androgen receptor modulators
2. 12209098 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
3. 12168650 - Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile
4. 12012398 - Bicyclic compounds as androgen receptor modulators
5. 11952386 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
6. 11667624 - Indole compounds as androgen receptor modulators
7. 10968235 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
8. 10336774 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
9. 10287266 - Compounds and compositions for inhibiting the activity of SHP2
10. 10077276 - N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
11. RE46942 - 4-piperidinyl compounds for use as tankyrase inhibitors
12. 9181266 - 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
13. 9163003 - 4-piperidinyl compounds for use as tankyrase inhibitors
14. 8957068 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
15. 8809352 - Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancer